{
    "data": [
        {
            "id": "4557970",
            "title": "Boeing lifts Africa aircraft demand forecast by 40% on strong economic growth",
            "description": "<html><body><p data-eci=\"true\">Boeing Africa (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/BA\" title=\"The Boeing Company\">BA</a></span>) significantly raised its long-term aircraft demand outlook for the continent, citing accelerating economic growth and rising air travel across the region.</p>\n<p>The company now projects that African carriers will require about 1,700 new aircraft over the next 20 years, up from a forecast of 1,200 planes issued last year and 1,000 projected three years ago. The updated estimate was shared Thursday in Nairobi by Managing Director Henok Teferra Shawl.</p>\n<p>Narrowbody jets are expected to make up roughly two-thirds of future deliveries as airlines expand short- and medium-haul routes.</p>\n<p>Economic momentum in Sub-Saharan Africa is expected to outpace the global average this year. The International Monetary Fund forecasts the region’s output will rise 4.6% compared with 3.3% worldwide.</p>\n<p>Boeing (<a href=\"https://seekingalpha.com/symbol/BA\" title=\"The Boeing Company\">BA</a>) said passenger volumes in Africa are projected to increase about 6% annually over the coming years, supported by demographic trends such as a youthful population, an expanding middle class, ongoing urbanization and continued investment in airport infrastructure.</p>\n<p>Boeing (<a href=\"https://seekingalpha.com/symbol/BA\" title=\"The Boeing Company\">BA</a>) currently holds an estimated 70% share of the African aircraft market.</p>\n<p> </p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557970-boeing-lifts-africa-aircraft-demand-forecast-by-40-percent-on-strong-economic-growth",
            "pub_date": "2026-02-27 01:05:53",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557955",
            "title": "CNBC to cut nearly a dozen jobs as it unifies TV and digital ops - Reuters",
            "description": "<html><body><ul>\n<li data-testid=\"paragraph-0\">CNBC, the popular financial news organization that was recently spun out of Comcast (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a></span>) into a new networks-focused company, Versant (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/VSNT\" title=\"Versant Media Group, Inc.\">VSNT</a></span>), is restructuring its newsroom, <em>Reuters </em>reported Thursday, citing at least four sources.</li>\n<li data-testid=\"paragraph-0\">The news organization plans to merge its TV and digital operations, which would result in nearly a dozen layoffs, including the departure of the website's managing editor, Jeff McCracken, the report said.</li>\n<li data-testid=\"paragraph-1\">The cuts are part of an overhaul under Editor-in-Chief David Cho, as CNBC prepares to introduce a paywall on its website, sources told <em>Reuters</em>.</li>\n<li data-testid=\"paragraph-1\">\n<div data-testid=\"paragraph-2\">The layoffs are not aimed at cutting costs, and the news organization plans to add some 40 roles in the coming year, the report said.</div>\n<div data-testid=\"paragraph-7\"> </div>\n</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557955-cnbc-to-cut-nearly-a-dozen-jobs-as-it-unifies-tv-and-digital-ops---reuters",
            "pub_date": "2026-02-27 01:05:53",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557946",
            "title": "EPA to shift at least half of waived biofuel obligations to big refiners - Reuters",
            "description": "<html><body><p data-eci=\"true\"><span>The Trump administration has settled on a plan that would require big oil refineries to comprise at least half of the biofuel blending volumes obligations waived in recent years under the Small Refinery Exemption program, Reuters reported Thursday.</span></p>\n<p><span>The decision could be a negative for larger oil refiners that have said additional blending obligations would raise their costs, but it could help the biofuel industry by boosting demand for blending credits, the <a href=\"https://www.reuters.com/sustainability/climate-energy/trump-epa-shift-least-half-waived-biofuel-obligations-big-refiners-sources-say-2026-02-26/\" rel=\"nofollow\" target=\"_self\" title=\"report\">report</a> said.</span></p>\n<p><span>Under the Renewable Fuel Standard, oil refineries must blend billions of gallons of ethanol and other biofuels into their fuel or buy RIN credits from those that do, but small refineries can waive obligations if they demonstrate economic hardship, and the agriculture and fuel industries disagree on whether to reallocate the exempted blending obligations to larger refiners.</span></p>\n<p><span>Officials with the Environmental Protection Agency </span><span>have signaled recently that they settled on reallocating at least 50% of the waived volumes for 2023-25, and the level could go higher, according to the report.</span></p>\n<p><span>The EPA also sent its proposed 2026 and 2027 biofuel blending quotas to the White House on Wednesday, with a final rule expected before the end of March, an EPA administrator said this week at an ethanol conference in Florida.</span></p>\n<p><span>Potentially relevant stocks include Valero Energy (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a></span>), Marathon Petroleum (<a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corporation\">MPC</a>), Phillips 66 (<a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a>), HF Sinclair (<a href=\"https://seekingalpha.com/symbol/DINO\" title=\"HF Sinclair Corporation\">DINO</a>), PBF Energy (<a href=\"https://seekingalpha.com/symbol/PBF\" title=\"PBF Energy Inc.\">PBF</a>), Delek US (<a href=\"https://seekingalpha.com/symbol/DK\" title=\"Delek US Holdings, Inc.\">DK</a>), Archer Daniels Midland (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/ADM\" title=\"Archer-Daniels-Midland Company\">ADM</a></span>), Bunge (<a href=\"https://seekingalpha.com/symbol/BG\" title=\"Bunge Global SA\">BG</a>), Green Plains (<a href=\"https://seekingalpha.com/symbol/GPRE\" title=\"Green Plains Inc.\">GPRE</a>), Gevo (<a href=\"https://seekingalpha.com/symbol/GEVO\" title=\"Gevo, Inc.\">GEVO</a>), Clean Energy Fuels (<a href=\"https://seekingalpha.com/symbol/CLNE\" title=\"Clean Energy Fuels Corp.\">CLNE</a>), REX American Resources (<a href=\"https://seekingalpha.com/symbol/REX\" title=\"REX American Resources Corporation\">REX</a>), Darling Ingredients (<a href=\"https://seekingalpha.com/symbol/DAR\" title=\"Darling Ingredients Inc.\">DAR</a>), FutureFuel (<a href=\"https://seekingalpha.com/symbol/FF\" title=\"FutureFuel Corp.\">FF</a>).</span></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557946-epa-to-shift-at-least-half-of-waived-biofuel-obligations-to-big-refiners-reuters",
            "pub_date": "2026-02-27 00:56:29",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557959",
            "title": "Quebecor declares $0.40 dividend",
            "description": "<html><body><ul>\n<li>Quebecor (QBR.A:CA) declares <a href=\"https://seekingalpha.com/pr/20414811-quebecor-inc-reports-consolidated-results-for-fourth-quarter-and-full-year-2025\" target=\"_blank\">$0.40/share quarterly dividend</a>.</li>\n<li>Payable April 7; for shareholders of record March 13; ex-div March 13.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557959-quebecor-declares-0_40-dividend",
            "pub_date": "2026-02-27 00:56:29",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557954",
            "title": "TopBuild outlines $6.075B revenue midpoint for 2026 as M&A and operational discipline drive outlook",
            "description": "<html><body><p data-eci=\"true\">Earnings Call Insights: TopBuild Corp. (BLD) Q4 2025</p>\n<h3>Management View</h3>\n<ul>\n<li><p>CEO Robert Buck reiterated TopBuild’s “clear, profitable growth strategy and a proven track record of delivering compounded growth and strong shareholder returns.” Buck noted “significant growth opportunities across our $95 billion total addressable market” and highlighted strong free cash flow and disciplined capital deployment, both organically and through M&amp;A. He stated, “In the fourth quarter, weakness in the residential and light commercial end markets persisted. Consumer confidence remains low, interest rates are still elevated, and affordability continues to be an issue, all drivers of muted demand in the current environment.” However, Buck emphasized, “the commercial and industrial end markets remain solid...bidding and backlogs are healthy, and we're well positioned to capitalize.”</p></li>\n<li><p>Buck detailed the completion of seven acquisitions in 2025, including SPI in Q4, which fueled a 13.2% sales rise to $1.49 billion for the quarter. He confirmed that “acquisitions continue to be our top priority for capital allocation,” citing $1.9 billion deployed across the business and the addition of approximately $1.2 billion in annual revenue. Buck also announced the recent acquisition of Johnson Roofing, expanding commercial roofing operations in Texas, Louisiana, and Oklahoma.</p></li>\n<li><p>COO John Achille described ongoing operational excellence initiatives, including inventory management and technology platform integration, stating, “Our field teams are doing a great job managing profitability. As soft demand has persisted, we are responding appropriately and making disciplined pricing and volume decisions at the local level.” He added, “We are making great progress on integrating SPI...and we've identified several cross-selling opportunities we expect to realize over time.” Achille confirmed the SPI IT integration is expected to be completed by the end of Q2 2026.</p></li>\n<li><p>CFO Robert Kuhns reflected on “extraordinary growth” over the past decade and provided detail on Q4 results. Kuhns stated, “Acquisitions contributed 23.0%, as both Progressive and SPI had solid quarters and exceeded our expectations...pricing added 0.7%...volume declined 10.5% driven by ongoing weakness in the residential and light commercial end markets.” He cited $265 million adjusted EBITDA for Q4 and $1.04 billion for the year, and commented on cost controls: “On a same branch basis, SG&amp;A was down $19 million or 20 basis points due to cost reduction actions taken during the year.”</p></li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li><p>Kuhns set 2026 guidance for sales of $5.925 billion to $6.225 billion and adjusted EBITDA of $1.005 billion to $1.155 billion. He stated, “The midpoint of our revenue guidance at $6.075 billion is based on the following key assumptions: Overall, we expect volume and price to each be down low-single digits in 2026. Residential sales...will be down mid-single digits, inclusive of both volume and price. Commercial and industrial...is expected to grow low single digits.” M&amp;A closed in the last 12 months is expected to contribute $800 million to $850 million in revenue.</p></li>\n<li><p>Kuhns added, “The midpoint of our adjusted EBITDA guidance at $1.08 billion assumes the following: an EBITDA decremental of approximately 27% on lower volumes; $55 million of price/cost headwinds; and EBITDA margin on M&amp;A in the mid-teens, inclusive of $15 million of Progressive and SPI synergies that will impact 2026.”</p></li>\n<li><p>Buck commented, “while we expect demand will improve, it's not yet clear what that timing will be and it is too early in the year to bank on a second half recovery. This uncertainty is baked into our guidance.”</p></li>\n</ul>\n<h3>Financial Results</h3>\n<ul>\n<li><p>Kuhns reported Q4 net sales of $1.49 billion, up 13.2% year-over-year. Installation Services sales were $798 million, with M&amp;A contributing 16.3%. Specialty Distribution sales totaled $755 million, up 25.5%, with acquisitions contributing 28.9%. Adjusted gross profit was $416 million, margin of 28%. Adjusted EBITDA margin was 17.9% for Q4. Fourth quarter adjusted earnings were $4.50 per diluted share. Cash was $185 million with total liquidity at $1.1 billion.</p></li>\n<li><p>Kuhns highlighted an increase in interest and other expense to $36 million due to expanded credit facilities and new bonds. Working capital was $959 million or 15.4% of sales. Free cash flow for 2025 was $697 million. The company returned $434 million to shareholders via buybacks.</p></li>\n</ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li><p>Richard Reid, Wells Fargo: Asked about the guide path for single-family starts and differences between public and private builders. Buck responded that “the regional builders, the private regional builders are keeping very cost competitive...smaller custom builders...seem to definitely be holding their own relative to demand.”</p></li>\n<li><p>Reid also inquired about commercial and industrial backlogs. Buck explained, “typically, lighter commercial does follow residential. But we see some trending there in the right direction, we believe. But again, more optimism on the mechanical and the commercial roofing side.”</p></li>\n<li><p>Michael Rehaut, JPMorgan: Focused on pricing trends and the $55 million price/cost headwind. Kuhns replied, “it probably progressively gets a little worse as the year goes on. But we definitely saw some of that pressure in the fourth quarter.” Rehaut asked about specialty distribution leadership realignment. Achille responded, “just making sure we have the right leadership in place,” incorporating talent from SPI and DI.</p></li>\n<li><p>Susan Maklari, Goldman Sachs: Asked about cross-selling from the SPI integration. Achille indicated it is “connecting our sales teams and our managers,” with plans to add digital resources. Maklari also asked about cost structure flexibility. Kuhns said, “more than 70% of our costs are variable. So we can adjust quickly and make changes where we need to.”</p></li>\n<li><p>Margaret Grady, Jefferies: Inquired about pricing and margin guidance. Kuhns said, “the price cost bucket, it's obviously a mixed bag of products, some with price inflation, some with price pressure and price deflation.” He noted mechanical insulation pricing remains strong, while fiberglass and spray foam face pressure.</p></li>\n<li><p>Kenneth Zener, Seaport Research: Pressed on residential volume declines and regional differences. Kuhns stated, “December slowed significantly on the resi side...commercial business...about half...is light commercial work. That's been slow throughout the year.” Achille added, “Florida...it's a bit optimistic down there...Texas, probably still a little flat to slow.”</p></li>\n<li><p>Michael Dahl, RBC: Asked about pricing pressure in fiberglass. Kuhns responded, “pricing is a local decision in our business...we think we do a really good job of adjusting to local markets...but just given the macro environment, we saw it in the fourth quarter.”</p></li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li><p>Analysts maintained a neutral to slightly cautious tone, with multiple questions centered on pricing pressure, volume trends, and the sustainability of cost reductions. Specific focus was given to the risk of continued headwinds in residential and light commercial segments, as well as M&amp;A integration outcomes.</p></li>\n<li><p>Management’s tone in prepared remarks was confident, emphasizing operational discipline and growth opportunities. During the Q&amp;A, management acknowledged macro uncertainty and persistent headwinds but remained focused on controllable factors. Kuhns stated, “we're focused 100% on driving these synergies and getting the results that we can control.”</p></li>\n<li><p>Compared to the previous quarter, analyst sentiment shifted further toward risk mitigation, while management’s confidence remained steady, with more explicit discussion of cautious guidance and contingency planning.</p></li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li><p>Guidance language shifted from a focus on year-end M&amp;A integration and margin resiliency in Q3 to explicit caution about near-term market recovery in Q4, with 2026 guidance assuming no significant change in end market conditions.</p></li>\n<li><p>Strategic focus moved further towards M&amp;A-driven expansion, operational excellence, and capturing synergies, while reiterating discipline in cost management.</p></li>\n<li><p>Key metrics showed an increase in sales and M&amp;A contribution, but gross margin and EBITDA margin declined quarter-over-quarter, primarily due to mix and price/cost headwinds.</p></li>\n<li><p>Analyst questions in both quarters concentrated on pricing, M&amp;A integration, and residential demand outlook, but Q4 included more probing about regional and product-specific trends.</p></li>\n<li><p>Management’s confidence in operational flexibility and synergy capture remained unchanged, though the tone became more measured regarding residential recovery timing.</p></li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li><p>Management identified persistent softness in residential and light commercial demand, driven by low consumer confidence, elevated interest rates, and affordability issues.</p></li>\n<li><p>Kuhns highlighted ongoing price/cost headwinds of $55 million for 2026, with margin pressure linked to mix and competitive pricing, especially in fiberglass and spray foam.</p></li>\n<li><p>Achille noted supply chain dynamics, with “fiberglass pipe insulation remains on allocation.”</p></li>\n<li><p>Analyst concerns centered on the durability of cost savings, pace of price recovery, and the timing of a residential market rebound.</p></li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>TopBuild’s leadership emphasized its disciplined M&amp;A strategy, operational flexibility, and robust free cash flow as key strengths amid a challenging macro environment. The company’s 2026 guidance reflects cautious assumptions about residential demand, offset by anticipated growth in commercial and industrial segments and significant contributions from recent acquisitions. Management remains focused on synergy realization and cost optimization, confident in its ability to adapt to evolving market conditions and deliver long-term shareholder value.</p>\n<p><a href=\"https://seekingalpha.com/symbol/bld/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557954-topbuild-outlines-6_075b-revenue-midpoint-for-2026-as-m-and-a-and-operational-discipline",
            "pub_date": "2026-02-27 00:50:59",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557956",
            "title": "International Seaways declares combined dividend of $2.15",
            "description": "<html><body><ul>\n<li>International Seaways (INSW) declares combined dividend of <a href=\"https://seekingalpha.com/pr/20414885-international-seaways-reports-fourth-quarter-and-full-year-2025-results\" target=\"_blank\">$2.15/share quarterly dividend</a>.</li>\n<li>Payable March 30; for shareholders of record Mar. 20; ex-div Mar. 20.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557956-international-seaways-declares-combined-dividend-of-215",
            "pub_date": "2026-02-27 00:50:59",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557950",
            "title": "Stella Jones GAAP EPS of C$0.91, revenue of C$727M",
            "description": "<html><body><ul>\n<li>Stella Jones <a href=\"https://seekingalpha.com/pr/20414782-stella-jones-announces-fourth-quarter-and-full-year-2025-results\">press release</a>  (STLJF): Q4  GAAP EPS of C$0.91.</li>\n<li>Revenue of C$727M.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557950-stella-jones-gaap-eps-of-c091-revenue-of-c727m",
            "pub_date": "2026-02-27 00:46:01",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557951",
            "title": "Nordic American Tankers declares $0.17 dividend",
            "description": "<html><body><ul>\n<li>Nordic American Tankers (NAT) declares <a href=\"https://seekingalpha.com/pr/20414879-nordic-american-tankers-ltd-nyse-nat-report-as-per-december-31-2025-full-speed-ahead\" target=\"_blank\">$0.17/share quarterly dividend</a>.</li>\n<li>Payable March 24; for shareholders of record March 10; ex-div March 10.</li>\n<li><a href=\"https://seekingalpha.com/symbol/NAT/dividends?source=news_bullet\">See NAT Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557951-nordic-american-tankers-declares-0_17-dividend",
            "pub_date": "2026-02-27 00:46:01",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557908",
            "title": "uniQure falls after FDA commissioner’s comments on rare disease therapy",
            "description": "<html><body><p data-eci=\"true\">uniQure (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/QURE\" title=\"uniQure N.V.\">QURE</a></span></span>) shares fell ~28% on Thursday after FDA Commissioner Marty Makary, in a potential reference to Danish biotech’s gene therapy AMT-130, suggested his agency will not approve drugs that are associated with patient morbidity.</p>\n<p>His comments come at a time when uniQure (<a href=\"https://seekingalpha.com/symbol/QURE\" title=\"uniQure N.V.\">QURE</a>) is seeking FDA accelerated approval for AMT-130, which is designed to treat a rare genetically driven neurodegenerative disorder <a href=\"https://seekingalpha.com/news/4538012-uniqure-gains-as-fda-sets-up-meeting-on-gene-therapy\" rel=\"noopener\" target=\"_blank\">called Huntington’s disease.</a></p>\n<p>During an interview with CNBC on rare-disease drug approvals on Thursday, Makary said, \"I think there has been a bit of an effort to find a boogeyman to account for certain products that were not approved.”</p>\n<p>“For example, there was a product where the researchers drilled a burr hole, literally a hole in people's skulls, to interact inject intrathecally into the ventricle\" as part of a randomized controlled trial.</p>\n<p>AMT-130 is administered directly into patients’ brain tissue through a neurosurgical procedure. “At the end of the randomization period, it's found no benefit, and yet, this is one of the drugs that we were pressured to approve,” Makary added.</p>\n<p>“I have a lot of sympathy for those patients. There's <a href=\"https://x.com/adamfeuerstein/status/2027027966945829196?s=20\" rel=\"noopener\" target=\"_blank\">nothing out</a> there to offer them, but we're not going to go ahead and approve something like that that has morbidity associated with it,” he said.</p>\n<p><span data-preserver-spaces=\"true\">However, Leerink Partners reaffirmed its Outperform rating on uniQure (<a href=\"https://seekingalpha.com/symbol/QURE\" title=\"uniQure N.V.\">QURE</a>), arguing that the drug Makary referred to could be </span><span data-preserver-spaces=\"true\">Regenxbio’s</span><span data-preserver-spaces=\"true\"> (<a href=\"https://seekingalpha.com/symbol/RGNX\" title=\"REGENXBIO Inc.\">RGNX</a>) RGX-121 and not AMT-130.</span></p>\n<p><span data-preserver-spaces=\"true\">A gene therapy targeting rare neurodegenerative diseases known as Mucopolysaccharidosis II (MPS II) and Mucopolysaccharidosis type I (MPS I), RGX-121, is delivered intrathecally into a ventricle using burr holes, analyst Joseph Schwartz argued. </span></p>\n<p><span data-preserver-spaces=\"true\">He added that it is not the </span><span data-preserver-spaces=\"true\">FDA's</span><span data-preserver-spaces=\"true\"> policy to comment on a drug under its review. Instead,</span><span data-preserver-spaces=\"true\"> “</span><span data-preserver-spaces=\"true\">this suggests this was about a drug that had been officially reviewed and rejected,</span><span data-preserver-spaces=\"true\">” </span><span data-preserver-spaces=\"true\">the analyst wrote, referring to RGX-121, for which the FDA issued a complete response </span><a href=\"https://seekingalpha.com/news/4549257-regenxbio-stock-drops-on-fda-setback-for-rgx-121-gene-therapy\" rel=\"noopener\" target=\"_blank\"><span data-preserver-spaces=\"true\">letter earlier this month</span></a><span data-preserver-spaces=\"true\">.</span></p>\n<p><em><span data-preserver-spaces=\"true\">Update 11.37 AM ET: Adds comments from Leerink Partners</span></em></p>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557908-uniqure-falls-fda-commissioners-comments",
            "pub_date": "2026-02-27 00:40:50",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557948",
            "title": "Cascades Non-GAAP EPS of $0.40, revenue of $4.77M",
            "description": "<html><body><ul>\n<li>Cascades <a href=\"https://seekingalpha.com/pr/20414789-cascades-reports-results-for-the-fourth-quarter-and-full-year-2025\">press release</a>  (CADNF): Q4  Non-GAAP EPS of C$0.40.</li>\n<li>Revenue of C$4.77M.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557948-cascades-non-gaap-eps-of-0_40-revenue-of-4_77m",
            "pub_date": "2026-02-27 00:40:50",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}